FDA Inspection 1056894 — Anne Lynn Su Chang, M.D.
The FDA completed an inspection of Anne Lynn Su Chang, M.D. on Jun 13, 2018 in Redwood City, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Redwood City, CA (United States)
Additional details
Clinical Investigator (CI)